Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opko Health
Pharma
Pfizer, Opko gain FDA nod for weekly growth hormone drug Ngenla
With an FDA blessing for once-weekly growth hormone deficiency drug Ngenla, Pfizer has racked up four approvals over the last five weeks.
Kevin Dunleavy
Jun 28, 2023 10:42am
Pfizer gets EU approval for long-acting human growth hormone
Feb 22, 2022 7:30am
Pfizer’s rare disease plan takes surprising hit
Jan 24, 2022 10:19am
Phillip Frost pays $5.5M to settle SEC stock manipulation charges
Jan 2, 2019 12:16pm
Opko enters animal health market with big plans for oncology
Oct 28, 2016 10:10am
